We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard ...

Avacta is slated to present the final Phase Ia dose escalation data for our lead program, faridoxorubicin. This will be at ESMO 2025 in Berlin, a little bit later next month in October of 2025. There, ...

Bill Briggs, chief technology officer at Deloitte, acknowledged a “vibe shift” around AI but said it’s not comparable to the ...

Julie Gould learns of a career planning framework that can help pinpoint what you love about your current role, and how that ...

We thought happiness peaked at the beginning and end of life, but a study from Germany suggests a more pessimistic outlook ...

I see extreme undervaluation in certain high-yield dividend stocks facing temporary macro headwinds. Read the full analysis ...

The math score gender gap widened during the coronavirus pandemic, and schools and academic organizations are trying to respond.